Thank you, Dan. I will review third quarter 2021 financial results. In the third quarter, we recorded $121,000 in grant revenue, as offsetting cost of grant revenue as we continued our work on the Navy funded NAVSEA demonstration under the DTI subcontract, which began in mid 2020. As we've noted on previous calls, the amount of grant revenue recognized each quarter will vary, as this is a function of the timing of spending in scheduled milestones under the program. We continue to expect almost all of the grant revenue for this program and our SBIR Phase 1 project to be recognized by early next year. Operating expenses were $1.2 million in the third quarter of 2021, flat compared to $1.2 million in the third quarter of 2020. While we invested over $200,000 more in research and development and sales and marketing in the third quarter, compared to the third quarter of 2020. This increase was largely offset by lower general and administrative expenses. We continue to expect research and development and sales and marketing spending to trend higher in the fourth quarter and throughout 2022 As we accelerate development and commercialization of our B-TRAN technology, including conducting additional wafer fabrication runs, third-party testing of the B-TRAN, adding more engineering and front end talent supporting our Test and Evaluation program, designing an intelligent power module and other B-TRAN commercialization activities with potential new customers and partners. We do expect some quarter-to-quarter variability in operating expenses, particularly our research and development spending due to the timing of semiconductor fabrication runs and other development activities. Net was in the third quarter of 2021 was $1.2 million, compared to $4.9 million in the third quarter of 2020. The year-ago period included a one-time non cash warrant inducement expense of $3.7 million. Third quarter 2021 cash used in operating and investing activities was $1.2 million, up from $0.8 million in the third quarter of 2020 and $1.1 million in the second quarter of this year. Our third quarter cash burn was consistent with the guidance we provided in our second quarter call. We continue to invest in both sales and marketing and research and development, expect fourth quarter cash burn of approximately $1.3 million in a full year cash burn of approximately $4.5 million. Cash and cash equivalents totaled $24.5 million in September 30, 2021. Our balance sheet gives us ample liquidity, particularly given our plan continued modest cash burn to fund multiple years of operations. And we are a well capitalized partner for the larger companies that are engaged and we expect to engage in the testing and evaluation of our B-TRAN technology. As of September 30, we had 5,872,046 shares outstanding and 1,040,248 warrants outstanding, including 455,937 stock options outstanding, our diluted shares outstanding and September 30 was 7.4 million shares unchanged from our diluted shares outstanding at June 30. At this time, I'd like to open up the call for questions. Operator?